vorinostat has been researched along with santacruzamate a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balunas, MJ; Engene, N; Gerwick, WH; Lopez, DD; McPhail, KL; Ononye, S; Pavlik, CM; Wong, CY | 1 |
| Balunas, MJ; deMayo, JA; Gromek, SM; Li, J; Maxwell, AT; Pavlik, CM; West, AM; Wiemer, AJ; Zhao, Z; Zweifach, A | 1 |
| Gazzerro, P; Mazitschek, R; Randino, R; Rodriquez, M | 1 |
3 other study(ies) available for vorinostat and santacruzamate a
| Article | Year |
|---|---|
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.
Topics: Carbamates; Cyanobacteria; Cytotoxins; Drug Screening Assays, Antitumor; HCT116 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leishmania donovani; Lymphoma, T-Cell; Molecular Structure; Panama; Parasitic Sensitivity Tests; Plasmodium falciparum; RNA, Ribosomal, 16S; Structure-Activity Relationship; Trypanosoma cruzi; Vorinostat | 2013 |
Synthesis and biological evaluation of santacruzamate A analogues for anti-proliferative and immunomodulatory activity.
Topics: Antineoplastic Agents; Carbamates; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; MCF-7 Cells; Molecular Structure; Structure-Activity Relationship; T-Lymphocytes, Cytotoxic | 2016 |
Synthesis and biological evaluation of Santacruzamate-A based analogues.
Topics: Antineoplastic Agents; Carbamates; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured | 2017 |